#United States #New York City #Global Summit #KFSHRC #C3 International

C3 International Concludes Landmark Global Summit Series in Healthcare

C3 International, recognized for its initiative known as the Davos of Healthcare™, has recently concluded a successful global summit series in collaboration with the King Faisal Specialist Hospital & Research Centre (KFSHRC). This noteworthy event unfolded across two major cities: New York City and Tokyo, attracting influential leaders and innovators in the healthcare sector.

The journeys of these apex summits began with the U.S. C3 Davos of Healthcare™, held on September 8, 2025, in New York City. The event was initiated with a warm welcome from Dr. Bjorn Zoëga, the Deputy Chief Executive Officer at KFSHRC. Dr. Zoëga introduced the keynote speaker, General David Petraeus, who holds prominent positions at KKR and shared his insights on the future of healthcare innovation. The highlight of the day was the inaugural C3 Davos of Healthcare™ Global Innovation Award, presented to Dr. Sam Waksal, the Chairman, CEO, and President of Graviton Bioscience, the summit's main sponsor.

Moving eastward, the next significant event unfolded at The Okura Hotel in Tokyo on September 24, 2025. This summit embraced the spirit of international collaboration, culminating in the presentation of the C3 Global Healthcare Leadership Award to Dr. Majid Alfayyadh, the Chief Executive Officer of KFSHRC. Former Japanese Minister of the Environment and State Minister of Health, Labour and Welfare, Dr. Ichiro Kamoshita, delivered the award, emphasizing the importance of leadership in advancing global healthcare initiatives.

One of the standout features of this summit series was the King Faisal Davos of Healthcare Innovation Challenge, which serves as a global platform for transformative medical technology developments. In the year 2025, the challenge recognized two pioneering companies: BioCurie from New York City for its revolutionary contributions in cancer research, and Gifts, Inc. from Tokyo for its exceptional advancements in regenerative medicine and biotechnology.

In remarks reflecting on the summit series, Ransel Potter, Founder and Managing Partner of C3 International, expressed pride in showcasing the remarkable potential of global collaboration in tackling healthcare challenges. He emphasized how the events in New York and Tokyo underscored the necessity for unifying efforts to overcome common health obstacles faced worldwide.

The successful summits not only highlight C3 International's position as a key facilitator in healthcare innovation, but they also provided a unique forum where leaders from governmental, hospital, and investment sectors could convene to address pressing health issues and strategize viable solutions. Since its inception, C3 International has firmly established itself within the global healthcare discourse, securing its recognition as an